Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients

Background and Objectives: To report the real-life Brolucizumab therapeutical outcomes of treatment-naïve and non-treatment-naïve eyes with neovascular age-related macular degeneration (nAMD) and to analyze the incidence of therapy-related adverse events. Materials and Methods: A total of 56 eyes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gesualdo, Carlo, Rossi, Settimio, Iodice, Clemente Maria, Guarino, Francesco, Petrella, Mariachiara, D’Agostino, Fabiana Anna, Perrotta, Raffaele, Simonelli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304196/
https://www.ncbi.nlm.nih.gov/pubmed/37374314
http://dx.doi.org/10.3390/medicina59061110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304196/
https://www.ncbi.nlm.nih.gov/pubmed/37374314
http://dx.doi.org/10.3390/medicina59061110

Ejemplares similares